MicroRNA-106b~25 expressions in tumor tissues and plasma of patients with gastric cancers

Medical Oncology

Volumn 31, Issue 10, 2014, Pages 1-8

  Zhang, Rupeng ^a   Wang, Weijia ^a   Li, Fangxuan ^a   Zhang, Hui ^a   Liu, Juntian ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Clinical pathological factors; Gastric cancer; MicroRNA 106b 25

Indexed keywords

D DIMER; MICRORNA; MICRORNA 106B 25; TUMOR MARKER; UNCLASSIFIED DRUG; MIRN106 MICRORNA, HUMAN;

ADULT; AGE; AGED; ANEMIA; ARTICLE; BLOOD GROUP A; BLOOD GROUP AB; BLOOD GROUP B; BLOOD GROUP O; CANCER LOCALIZATION; CANCER SIZE; CANCER TISSUE; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE SEVERITY; DISTANT METASTASIS; FEMALE; GENDER; GENE CLUSTER; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; STOMACH CANCER; THROMBOCYTE COUNT; TUMOR DIFFERENTIATION; TUMOR INVASION; WEIGHT REDUCTION; BLOOD; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; NORMAL HUMAN; PATHOLOGY; PHYSIOLOGY; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; STOMACH TUMOR;

ADULT; AGED; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEALTHY VOLUNTEERS; HUMANS; LYMPHATIC METASTASIS; MALE; MICRORNAS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84908596543     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0243-x     Document Type: Article

References (28)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.
2. Lin Y, Ueda J, Kikuchi S, Totsuka Y, Wei WQ, Qiao YL, et al. Comparative epidemiology of gastric cancer between Japan and China. World J Gastroenterol. 2011;17(39):4421–8.
3. Lu YF, Liu ZC, Li ZH, Ma WH, Wang FR, Zhang YB, et al. Esophageal/gastric cancer screening in high-risk populations in Henan Province China. Asian Pac J Cancer Prev. 2014;15(3):1419–22.
4. Tsujiura M, Ichikawa D, Komatsu S, Shiozaki A, Takeshita H, Kosuga T, et al. Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer. 2010;102(7):1174–9.
5. Tong F, Cao P, Yin Y, Xia S, Lai R, Liu S. MicroRNAs in gastric cancer: from benchtop to bedside. Dig Dis Sci. 2014;59(1):24–30.
6. Li B, Shi XB, Nori D, Chao CK, Chen AM, Valicenti R, et al. Down-regulation of microRNA 106b is involved in p21-mediated cell cycle arrest in response to radiation in prostate cancer cells. Prostate. 2011;71(6):567–74.
7. Zhang A, Hao J, Wang K, Huang Q, Yu K, Kang C, et al. Down-regulation of miR-106b suppresses the growth of human glioma cells. J Neurooncol. 2013;112(2):179–89.
8. Slaby O, Jancovicova J, Lakomy R, Svoboda M, Poprach A, Fabian P, et al. Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy. J Exp Clin Cancer Res. 2010;29(90):90.
9. Poliseno L, Salmena L, Riccardi L, Fornari A, Song MS, Hobbs RM, et al. Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Sci Signal. 2010;3(117):ra29.
10. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–8.
11. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001;29(9):e45.
12. Wang J, Wang Q, Liu H, Hu B, Zhou W, Cheng Y. MicroRNA expression and its implication for the diagnosis and therapeutic strategies of gastric cancer. Cancer Lett. 2010;297(2):137–43.
13. Chen CZ. MicroRNAs as oncogenes and tumor suppressors. N Engl J Med. 2005;353(17):1768–71.
14. Greenberg E, Hajdu S, Nemlich Y, Cohen R, Itzhaki O, Jacob-Hirsch J, et al. Differential regulation of aggressive features in melanoma cells by members of the miR-17-92 complex clusters: polycistrons with oncogenic roles in hepatocellular carcinoma. Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma. Open Biol. 2014;4(6):140030.
15. Tan W, Li Y, Lim SG, Tan TM, Li X, Yang H, et al. Clusters: polycistrons with oncogenic roles in hepatocellular carcinoma. Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma. World J Gastroenterol. 2014;20(20):5962–72.
16. Li X, Yang H, Tian Q, Liu Y, Weng Y. Upregulation of microRNA-17-92 cluster associates with tumor progression and prognosis in osteosarcoma. Neoplasma. 2014;61(4):453–60.
17. Guo J, Miao Y, Xiao B, Huan R, Jiang Z, Meng D, et al. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J Gastroenterol Hepatol. 2009;24(4):652–7.
18. Ulivi P, Zoli W, Huang J, Zhang SY, Gao YM, Liu YF, et al. MiRNAs as non-invasive biomarkers for lung cancer diagnosis microRNAs as oncogenes or tumour suppressors in oesophageal cancer: potential biomarkers and therapeutic targets. Molecules. 2014;19(6):8220–37.
19. Huang J, Zhang SY, Gao YM, Liu YF, Liu YB, Zhao ZG, et al. MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: potential biomarkers and therapeutic targets. Cell Prolif. 2014;6(10):12109.
20. Kim YK, Yu J, Han TS, Park SY, Namkoong B, Kim DH, et al. Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res. 2009;37(5):1672–81.
21. Petrocca F, Vecchione A, Croce CM. Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. Cancer Res. 2008;68(20):8191–4.
22. Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, de Martino I, et al. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell. 2008;13(3):272–86.
23. Cai K, Wang Y, Bao X. MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma. J Exp Clin Cancer Res. 2011;30(73):73.
24. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105(30):10513–8.
25. Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM, Cohn DE. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol. 2009;112(1):55–9.
26. Schou JV, Rossi S, Jensen BV, Nielsen DL, Pfeiffer P, Hogdall E, et al. MiR-345 in metastatic colorectal cancer: a non-invasive biomarker for clinical outcome in non-kras mutant patients treated with 3rd line cetuximab and irinotecan genetic polymorphism of miR-196a as a prognostic biomarker for early breast cancer. PLoS One. 2014;9(6):e99886.
27. Lee SJ, Seo JW, Chae YS, Kim JG, Kang BW, Kim WW, et al. Genetic Polymorphism of miR-196a as a prognostic biomarker for early breast cancer. Anticancer Res. 2014;34(6):2943–9.
28. Li X, Shi Y, Yin Z, Xue X, Zhou B. An eight-miRNA signature as a potential biomarker for predicting survival in lung adenocarcinoma. J Transl Med. 2014;12(1):159.